David G Wang

Title: David G Wang: Innovator in P450 SNP Analysis

Introduction

David G Wang, based in Deerfield, IL, is a notable inventor with significant contributions to the field of biotechnology. He holds a patent for a groundbreaking invention that improves the methods used to determine single nucleotide polymorphisms (SNPs) in P450 genes, which are crucial for various biochemical processes in the body.

Latest Patents

David’s patent, titled "P450 single nucleotide polymorphism biochip analysis," focuses on techniques and compositions designed to enhance the detection of SNPs in P450 genes. This invention introduces novel non-self-extension probes and methods to prevent the self-extension of interrogation probes, thereby improving the specificity and efficiency of PCR detection. This innovation minimizes false positive results while providing a unique array of P450 SNP probes for use in assays. His patent includes specific primer sequences for the amplification of each of the seven P450 genes, along with control probes to verify successful amplification.

Career Highlights

David G Wang is affiliated with Amersham Biosciences, where he has applied his expertise in biochemistry and genetic analysis to push forward the boundaries of research. His work has been instrumental in developing methodologies that could enhance personalized medicine approaches by improving the accuracy of genetic testing related to drug metabolism.

Collaborations

In his career, David has collaborated with notable colleagues, including Buena Chui and Robert Elghanian. Together, they have contributed to innovative solutions that address significant challenges in bioanalysis and genetic screening.

Conclusion

David G Wang’s contributions extend beyond his patent, influencing the broader landscape of genetic research and personalized medicine. His work at Amersham Biosciences continues to pave the way for advancements in pharmacogenomics, demonstrating the importance of innovation in the field of biotechnology.